Mosunetuzumab
Modify Date: 2024-04-11 05:16:58
Mosunetuzumab structure
|
Common Name | Mosunetuzumab | ||
|---|---|---|---|---|
| CAS Number | 1905409-39-3 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MosunetuzumabMosunetuzumab (BTCT-4465A) is a humanized, immunoglobulin G1-based bispecific antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs)[1]. |
| Name | Mosunetuzumab |
|---|
| Description | Mosunetuzumab (BTCT-4465A) is a humanized, immunoglobulin G1-based bispecific antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs)[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |